Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Disclosure of cardiac variants of uncertain significance results in an exome cohort

View through CrossRef
This study examined the impact of disclosing subclassifications of genetic variants of uncertain significance (VUS) on behavioral intentions. We studied return of VUS results to 79 individuals with a cardiomyopathy‐associated VUS, subclassified into VUS‐high or VUS‐low. Primary outcomes were perceived risk (absolute and comparative), perceived severity, perceived value of information, self‐efficacy, decision regret, and behavioral intentions to share results and change behaviors. There was no significant difference between the 2 subclasses in overall behavioral intentions (t = 0.023, P = .982) and each of the individual items on the behavioral intentions scale; absolute (t = −1.138, P = .259) or comparative (t = −0.463, P = .645) risk perceptions; perceived value of information (t = 0.582, P = .563) and self‐efficacy (t = −0.733, P = .466). Decision regret was significantly different (t = 2.148, P = .035), with VUS‐low (mean = 17.24, SD = 16.08) reporting greater regret. Combining the subclasses, perceived value of information was the strongest predictor of behavioral intentions (β = 0.524, P < .001). Participants generally understood the meaning of a genetic VUS result classification and reported satisfaction with result disclosure. No differences in behavioral intentions were found, but differences in decision regret suggest participants distinguish subclasses of VUS results. The perceived value of VUS may motivate recipients to pursue health‐related behaviors.
Title: Disclosure of cardiac variants of uncertain significance results in an exome cohort
Description:
This study examined the impact of disclosing subclassifications of genetic variants of uncertain significance (VUS) on behavioral intentions.
We studied return of VUS results to 79 individuals with a cardiomyopathy‐associated VUS, subclassified into VUS‐high or VUS‐low.
Primary outcomes were perceived risk (absolute and comparative), perceived severity, perceived value of information, self‐efficacy, decision regret, and behavioral intentions to share results and change behaviors.
There was no significant difference between the 2 subclasses in overall behavioral intentions (t = 0.
023, P = .
982) and each of the individual items on the behavioral intentions scale; absolute (t = −1.
138, P = .
259) or comparative (t = −0.
463, P = .
645) risk perceptions; perceived value of information (t = 0.
582, P = .
563) and self‐efficacy (t = −0.
733, P = .
466).
Decision regret was significantly different (t = 2.
148, P = .
035), with VUS‐low (mean = 17.
24, SD = 16.
08) reporting greater regret.
Combining the subclasses, perceived value of information was the strongest predictor of behavioral intentions (β = 0.
524, P < .
001).
Participants generally understood the meaning of a genetic VUS result classification and reported satisfaction with result disclosure.
No differences in behavioral intentions were found, but differences in decision regret suggest participants distinguish subclasses of VUS results.
The perceived value of VUS may motivate recipients to pursue health‐related behaviors.

Related Results

Whole Exome Sequencing and Extended Thrombophilia Testing in Patients with Venous Thromboembolism
Whole Exome Sequencing and Extended Thrombophilia Testing in Patients with Venous Thromboembolism
Abstract Introduction: Venous thromboembolism (VTE), defined as deep venous thrombosis (DVT) and pulmonary embolism (PE), is a cause of significant morbidity and mor...
Cardiac Myxoma Post-Transseptal Ablation: Coincidence or Causation?
Cardiac Myxoma Post-Transseptal Ablation: Coincidence or Causation?
Background: Cardiac myxomas are benign cardiac neoplasms usually found solitarily located within a single cardiac chamber, most commonly in the left atrium. With no established cau...
Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical Care
Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical Care
PURPOSE Genetic testing has clinical utility in the management of patients with hereditary cancer syndromes. However, the increased likelihood of encountering a variant of uncertai...
Abstract 2094: Comparing exome with whole-genome next-generation sequencing in detecting somatic mutations
Abstract 2094: Comparing exome with whole-genome next-generation sequencing in detecting somatic mutations
Abstract Exome sequencing has been used as an efficient and cost-effective method of identifying somatic mutations in tumors. In order to evaluate the effectiveness ...
12488 Exome Sequencing Unravels New Susceptibility Genes For Pheochromocytomas And Paragangliomas
12488 Exome Sequencing Unravels New Susceptibility Genes For Pheochromocytomas And Paragangliomas
Abstract Disclosure: G.F. Fagundes: None. F.F. Castro: None. L.S. Santana: None. A.F. Afonso: None. A.W. Maciel: None. F.L. Ledesma: None. C.A. Pereira: None. I.C. S...
Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia
Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia
Objectives:Gene variants are important factors in prognosis of the patients with hematological malignancies. In current study, our team investigate the relationship between blood a...
Child, parent, and healthcare professionals’ perspectives on HIV infection status disclosure to children
Child, parent, and healthcare professionals’ perspectives on HIV infection status disclosure to children
Background. HIV disclosure is a challenging process for parents and healthcare professionals. The majority of HIV-infected persons live in Sub-Saharan Africa wher...

Back to Top